Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Food Chem ; 414: 135670, 2023 Jul 15.
Article in English | MEDLINE | ID: mdl-36827777

ABSTRACT

Unsaturated mannuronate oligosaccharide (MOS) is an acidic oligosaccharide prepared from alginate-derived polymannuronate by enzymatic depolymerization, followed by double bond formation between C-4 and C-5 at the nonreducing end. In this study, MOS was used as a stabilizer to fabricate O/W nanoemulsions loaded with curcumin (MOS-CUR) for the first time. The results revealed that the MOS-CUR showed small droplet sizes and narrow size distributions and was slightly more stable than normal oil-in-water (O/W) curcumin nanoemulsions (water-CUR). Additionally, MOS can improve the superoxide anion scavenging ability and iron ion reducing ability of the curcumin nanoemulsion system. Although the digestion behaviour of MOS-CUR and water-CUR was similar, the bioavailability of curcumin in MOS-CUR was significantly higher than that in water-CUR. All these results indicated that MOS could be used as a stabilizer for preparing nanoemulsions to easily encapsulate labile nutrients and to enhance the bioavailability and antioxidant capacity of these nutrients.


Subject(s)
Curcumin , Nanoparticles , Curcumin/chemistry , Emulsions/chemistry , Antioxidants/chemistry , Excipients , Biological Availability , Particle Size , Nanoparticles/chemistry
2.
Food Chem X ; 16: 100469, 2022 Dec 30.
Article in English | MEDLINE | ID: mdl-36299863

ABSTRACT

Unsaturated guluronate oligosaccharide (GOS) is generated via alginate-derived polyguluronate (PG) degradation by alginate lyase, followed by formation of a double bond between C-4 and C-5 at the nonreducing end. In this study, GOS was first used as a stabilizer to fabricate O/W nanoemulsions loaded with resveratrol (GOS-RES). Our results revealed that both the GOS-RES and normal O/W resveratrol nanoemulsions (water-RES) showed small droplet sizes and narrow size distributions under certain experimental conditions. However, the particle size and stability of the GOS-RES were slightly greater than those of the water-RES in acidic and neutral environments and at high temperatures. Furthermore, the GOS-RES exhibited a better sustained release effect for resveratrol than the water-RES. Moreover, the GOS-RES showed a significant superoxide radical scavenging effect. All these results demonstrated that GOS has good prospects for preparing nanoemulsions to encapsulate hydrophobic nutrients, which could be applied as food-grade components in beverages and other foods.

3.
Front Nutr ; 9: 892558, 2022.
Article in English | MEDLINE | ID: mdl-35662922

ABSTRACT

Alzheimer's disease (AD) is a neurodegenerative disorder mainly affecting old population. In this study, two Tau overexpressing cell lines (SH-SY5Y/Tau and HEK293/Tau), N2a/SweAPP cell line, and 3× Transgene (APPswe/PS1M146V/TauP301L) mouse primary nerve cell lines were used as AD models to study the activity and molecular mechanism of macelignan, a natural compound extracted from Myristica fragrans, against AD. Our study showed that macelignan could reduce the phosphorylation of Tau at Thr 231 site, Ser 396 site, and Ser 404 site in two overexpressing Tau cell lines. It also could decrease the phosphorylation of Tau at Ser 404 site in mouse primary neural cells. Further investigation of its mechanism found that macelignan could reduce the phosphorylation of Tau by increasing the level of autophagy and enhancing PP2A activity in Tau overexpressing cells. Additionally, macelignan could activate the PERK/eIF2α signaling pathway to reduce BACE1 translation, which further inhibits the cleavage of APP and ultimately suppresses Aß deposition in N2a/SweAPP cells. Taken together, our results indicate that macelignan has the potential to be developed as a treatment for AD.

4.
Mol Neurobiol ; 58(8): 4134-4144, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33948899

ABSTRACT

Alzheimer's disease (AD) is a devastating brain disorder characterized by neurofibrillary tangles and amyloid plaques. Inhibiting Tau protein and amyloid-beta (Aß) production or removing these molecules is considered potential therapeutic strategies for AD. Genipin is an aglycone and is isolated from the extract of Gardenia jasminoides Ellis fruit. In this study, the effect and molecular mechanisms of genipin on the inhibition of Tau aggregation and Aß generation were investigated. The results showed that genipin bound to Tau and protected against heparin-induced Tau fibril formation. Moreover, genipin suppressed Tau phosphorylation probably by downregulating the expression of CDK5 and GSK-3ß, and activated mTOR-dependent autophagy via the SIRT1/LKB1/AMPK signaling pathway in Tau-overexpressing cells. In addition, genipin decreased Aß production by inhibiting BACE1 expression through the PERK/eIF2α signaling pathway in N2a/SweAPP cells. These data indicated that genipin could effectively lead to a significant reduction of phosphorylated Tau level and Aß generation in vitro, suggesting that genipin might be developed into an effective therapeutic complement or a potential nutraceutical for preventing AD.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/metabolism , Iridoids/pharmacology , tau Proteins/antagonists & inhibitors , tau Proteins/metabolism , Alzheimer Disease/pathology , Animals , Cell Line, Tumor , Dose-Response Relationship, Drug , HEK293 Cells , Humans , Mice , Mice, Transgenic , Phosphorylation/drug effects , Phosphorylation/physiology , Protein Structure, Tertiary
5.
J Agric Food Chem ; 69(15): 4438-4445, 2021 Apr 21.
Article in English | MEDLINE | ID: mdl-33829789

ABSTRACT

Polymannuronate (PM) is an acidic polysaccharide prepared from alginate, contained in edible brown seaweeds. An unsaturated mannuronate oligosaccharide (MOS) is an enzymatically depolymerized oligosaccharide prepared from PM. The effects of MOS on attenuating tauopathy were studied in HEK293/Tau cells and primary triple transgenic (3×Tg) neurons. MOS inhibited heparin-induced aggregation of the Tau-K18 oligomer and suppressed the levels of phosphorylated Tau protein. MOS treatment reduced the activity of glycogen synthase kinase-3ß (GSK-3ß) by decreasing its phosphorylation levels on the sites of Y216 and increasing phosphorylation levels on the sites of S9. MOS treatment increased the ratio of LC3-II/LC3-I levels and reduced the expression of p62, indicating an increase in autophagy. Finally, MOS-induced decrease in Tau protein expression was attenuated by the addition of an autophagy inhibitor, confirming the involvement of autophagy. These data support MOS as a promising functional food or potential pharmaceutics for attenuating Tau protein-related disease.


Subject(s)
Alginates , Tauopathies , Autophagy , Glycogen Synthase Kinase 3 beta/genetics , HEK293 Cells , Humans , Oligosaccharides , Phosphorylation , tau Proteins/genetics , tau Proteins/metabolism
6.
Carbohydr Polym ; 264: 118047, 2021 Jul 15.
Article in English | MEDLINE | ID: mdl-33910749

ABSTRACT

Unsaturated guluronate oligosaccharide (GOS) was prepared from alginate-derived homopolymeric blocks of guluronic acid by alginate lyase-mediated depolymerization. In this study, a GOS-based water-in-oil-in-water (W1/O/W2) nanoemulsion was prepared, and different influencing factors were investigated. First, linseed oil was selected as the optimal carrier oil. Then, other optimal conditions of the GOS nanoemulsion were determined based on response surface methodology (RSM). Under the optimal conditions, the obtained GOS nanoemulsion showed a spherical structure with an average particle size of 273.93 ±â€¯8.91 nm, and its centrifugal stability was 91.37 ±â€¯0.45 %. Moreover, the GOS nanoemulsion could achieve the aim of sustained release in vitro and be stably stored at 4°C for at least 5 days. This work prepared a novel GOS-based W1/O/W2 nanoemulsion that may effectively address the storage difficulties of unsaturated GOS and provides a valuable contribution to the application of GOS in the food and medicine fields.


Subject(s)
Hexuronic Acids/chemistry , Nanostructures/chemistry , Oligosaccharides/chemistry , Alginates/chemistry , Delayed-Action Preparations/chemistry , Drug Carriers/chemistry , Drug Compounding/methods , Drug Stability , Emulsions/chemistry , Humans , Linseed Oil/chemistry , Oxidation-Reduction , Particle Size , Polysaccharide-Lyases/chemistry
7.
Sci Rep ; 7(1): 1663, 2017 05 10.
Article in English | MEDLINE | ID: mdl-28490734

ABSTRACT

Alginate, a natural acidic polysaccharide extracted from marine brown seaweeds, is composed of different blocks of ß-(1, 4)-D-mannuronate (M) and its C-5 epimer α-(1, 4)-L-guluronate (G). Alginate-derived guluronate oligosaccharide (GOS) readily activates macrophages. However, to understand its role in immune responses, further studies are needed to characterize GOS transport and signalling. Our results show that GOS is recognized by and upregulates Toll-like receptor 4 (TLR4) on RAW264.7 macrophages, followed by its endocytosis via TLR4. Increased expression of TLR4 and myeloid differentiation protein 2 (MD2) results in Akt phosphorylation and subsequent activation of both nuclear factor-κB (NF-κB) and mechanistic target of rapamycin (mTOR). Moreover, GOS stimulates mitogen-activated protein kinases (MAPKs); notably, c-Jun N-terminal kinase (JNK) phosphorylation depends on TLR4 initiation. All these events contribute to the production of inflammatory mediators, either together or separately. Our findings also reveal that GOS induces cytoskeleton remodelling in RAW264.7 cells and promotes macrophage proliferation in mice ascites, both of which improve innate immunity. Conclusively, our investigation demonstrates that GOS, which is dependent on TLR4, is taken up by macrophages and stimulates TLR4/Akt/NF-κB, TLR4/Akt/mTOR and MAPK signalling pathways and exerts impressive immuno-stimulatory activity.


Subject(s)
Alginates/pharmacology , Hexuronic Acids/pharmacology , Macrophages/metabolism , Signal Transduction , Toll-Like Receptor 4/metabolism , Animals , Cell Proliferation/drug effects , Cytoskeleton/metabolism , Endocytosis , Endotoxins , Gene Knockdown Techniques , HEK293 Cells , Hexuronic Acids/chemistry , Humans , MAP Kinase Signaling System/drug effects , Macrophages/drug effects , Mice , Models, Biological , Peritoneum/metabolism , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , RAW 264.7 Cells , TOR Serine-Threonine Kinases/metabolism
8.
Mar Drugs ; 13(9): 5828-46, 2015 Sep 16.
Article in English | MEDLINE | ID: mdl-26389923

ABSTRACT

Alginate from marine brown algae has been widely applied in biotechnology. In this work, the effects of alginate-derived oligosaccharide (AdO) on lipopolysaccharide (LPS)/ß-amyloid (Aß)-induced neuroinflammation and microglial phagocytosis of Aß were studied. We found that pretreatment of BV2 microglia with AdO prior to LPS/Aß stimulation led to a significant inhibition of production of nitric oxide (NO) and prostaglandin E2 (PGE2), expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) and secretion of proinflammatory cytokines. We further demonstrated that AdO remarkably attenuated the LPS-activated overexpression of toll-like receptor 4 (TLR4) and nuclear factor (NF)-κB in BV2 cells. In addition to the impressive inhibitory effect on neuroinflammation, we also found that AdO promoted the phagocytosis of Aß through its interaction with TLR4 in microglia. Our results suggested that AdO exerted the inhibitory effect on neuroinflammation and the promotion effect on microglial phagocytosis, indicating its potential as a nutraceutical or therapeutic agent for neurodegenerative diseases, particularly Alzheimer's disease (AD).


Subject(s)
Alginates/chemistry , Amyloid beta-Peptides/metabolism , Microglia/drug effects , Oligosaccharides/chemistry , Oligosaccharides/pharmacology , Phagocytosis/drug effects , Amyloid beta-Peptides/toxicity , Animals , Cell Line , Cell Survival/drug effects , Cytokines/genetics , Cytokines/metabolism , Dinoprostone/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Inflammation/drug therapy , Lipopolysaccharides/toxicity , Microglia/physiology , Nitric Oxide/metabolism
9.
Mar Drugs ; 13(4): 1798-818, 2015 Mar 30.
Article in English | MEDLINE | ID: mdl-25830683

ABSTRACT

Alginate is a natural polysaccharide extracted from various species of marine brown algae. Alginate-derived guluronate oligosaccharide (GOS) obtained by enzymatic depolymerization has various pharmacological functions. Previous studies have demonstrated that GOS can trigger the production of inducible nitric oxide synthase (iNOS)/nitric oxide (NO), reactive oxygen species (ROS) and tumor necrosis factor (TNF)-α by macrophages and that it is involved in the nuclear factor (NF)-κB and mitogen-activated protein (MAP) kinase signaling pathways. To expand upon the current knowledge regarding the molecular mechanisms associated with the GOS-induced immune response in macrophages, comparative proteomic analysis was employed together with two-dimensional electrophoresis (2-DE), matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS) and Western blot verification. Proteins showing significant differences in expression in GOS-treated cells were categorized into multiple functional pathways, including the NF-κB signaling pathway and pathways involved in inflammation, antioxidant activity, glycolysis, cytoskeletal processes and translational elongation. Moreover, GOS-stimulated changes in the morphologies and actin cytoskeleton organization of RAW264.7 cells were also investigated as possible adaptations to GOS. This study is the first to reveal GOS as a promising agent that can modulate the proper balance between the pro- and anti-inflammatory immune responses, and it provides new insights into pharmaceutical applications of polysaccharides.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Drug Design , Gene Expression Regulation/drug effects , Macrophages/drug effects , Oligosaccharides/pharmacology , Polysaccharides, Bacterial/pharmacology , Alginates/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Antioxidants/chemistry , Antioxidants/metabolism , Carbohydrate Sequence , Cell Nucleus/drug effects , Cell Nucleus/immunology , Cell Nucleus/metabolism , Cell Nucleus Size/drug effects , Cell Size/drug effects , Glucuronic Acid/metabolism , Hexuronic Acids/metabolism , Hydrolysis , MAP Kinase Signaling System/drug effects , Macrophage Activation/drug effects , Macrophages/cytology , Macrophages/immunology , Macrophages/metabolism , Mice , Molecular Weight , Oligosaccharides/chemistry , Oligosaccharides/metabolism , Peptide Mapping , Polysaccharide-Lyases/metabolism , Polysaccharides, Bacterial/chemistry , Polysaccharides, Bacterial/metabolism , Proteomics/methods , RAW 264.7 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...